Napa 2019 • Request an Invite →
Founder and CEO of Brooks Bell Inc.
CEO and Fund Manager, Renaissance Venture Capital Fund
Chairman, CEO, & Founder, Alexandria Real Estate Equities
Software Engineer at Skelmir
Medical College of Wisconsin director of research commercialization
April 8, 2019 · Boston
May 21, 2019 · Boston
May 29, 2019 · San Diego
Retrophin is a rare disease startup founded by former hedge fund manager Martin Shkreli.
Sponsored · Whitepaper
Remain compliant and ensure optimal productivity
Xconomy Insight · Special Report
Get advice from the experts to help your biotech startup succeed
Implementing electronic solutions for risk mitigation
Xconomy offers a number of ways to subscribe for free!
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit/Ann Arbor, San Francisco, New York, Raleigh-Durham, Boulder/Denver, Texas, Wisconsin, Indiana, and beyond.
© 2007-2019, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Website development support from Andrew Koyfman with design support from Rob Hunter.